Extended Benefit with Bronchitol in Second Phase III Cystic Fibrosis Trial

16th Dec 10

Release Date: 16/12/2010 12:00am

Pharmaxis today announced positive first results for the open label component of its second international Phase III trial of Bronchitol in people with cystic fibrosis.


Read full media release - pdf

Categories: News and Media